SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-082715
Filing Date
2023-07-20
Accepted
2023-07-20 16:08:42
Documents
3
Period of Report
2023-07-20

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2318572d1_6k.htm 6-K 13528
2 EXHIBIT 99.1 tm2318572d1_ex99-1.htm EX-99.1 13460
3 GRAPHIC tm2318572d1_ex99-1img001.jpg GRAPHIC 4098
  Complete submission text file 0001104659-23-082715.txt   34036
Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Filer) CIK: 0001962738 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41666 | Film No.: 231099818
SIC: 2834 Pharmaceutical Preparations